Pfizer Declares A 20-Cent Third-Quarter 2011 Dividend

NEW YORK--(BUSINESS WIRE)-- The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 20-cent third-quarter 2011 dividend on the company’s common stock, payable September 6, 2011, to shareholders of record at the close of business on August 5, 2011.

The third-quarter 2011 cash dividend will be the 291st consecutive quarterly dividend paid by Pfizer.



CONTACT:

Pfizer Inc.
Media:
Joan Campion, 212-733-2798
or
Investors:
Suzanne Harnett, 212-733-8009

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Other Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The takeover centers on a near-approval anti-CGRP antibody that could address Lundbeck’s need for near-term revenue drivers.

Amplyx revealed early data for its lead program in candidemia and licensed a phase 2-ready program for BK virus infection from Novartis.

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”